FRENCH NORMATIVE REFERENCE DATA FOR THE QUALITY OF LIFE ASSESSMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS (QOL-AGHDA) QUESTIONNAIRE

被引：0
|
作者：
Chachuat, A. [1 ]
Koltowska-Haggstrom, M. [2 ]
Gilet, H. [3 ]
Auziere, S. [4 ]
Guillaume, X. [4 ]
Arnould, B. [3 ]
Viala-Danten, M. [3 ]
机构：
[1] Pfizer, Paris, France
[2] Pfizer Endocrine Care, KIMS Med Outcomes, Sollentuna, Sweden
[3] Mapi Values, Lyon, France
[4] TNS Healthcare, Montrouge, France
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66223-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A355 / A355
页数：1
相关论文
共 50 条
  • [41] Quality of life in transition phase in adolescents and young adults with severe and partial growth hormone deficiency
    Oswiecimska, Joanna
    Roczniak, Wojciech
    Romanowicz, Dagmara
    Szymlak, Agnieszka
    Mikolajczak, Agata
    Malczyk, Zaneta
    Stojewska, Malgorzata
    Ziora, Katarzyna
    NEUROENDOCRINOLOGY LETTERS, 2014, 35 (08) : 676 - 683
  • [42] The development, reliability and validity of a disease specific quality of life model for adults with growth hormone deficiency
    Wallymahmed, ME
    Baker, GA
    Humphris, G
    Dewey, M
    MacFarlane, IA
    CLINICAL ENDOCRINOLOGY, 1996, 44 (04) : 403 - 411
  • [43] Normal response data for the pancreatic cancer quality of life (QoL) assessment questionnaire eortc QLP-PAN26
    Howse, F.
    Harris, S.
    Hedges, E.
    George, S.
    Pickering, R.
    Johnson, C. D.
    PANCREAS, 2006, 33 (04) : 469 - 469
  • [44] Development and Psychometric Evaluation of the Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) to Assess Growth Hormone Injection Burden in Children and Adults
    Diane M. Turner-Bowker
    Andrew Yaworsky
    Andrew Palladino
    Roger E. Lamoureux
    Masami Kelly
    Emily Love
    Andreas M. Pleil
    Alan Shields
    Jane Loftus
    The Patient - Patient-Centered Outcomes Research, 2020, 13 : 289 - 306
  • [45] Development and Psychometric Evaluation of the Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) to Assess Growth Hormone Injection Burden in Children and Adults
    Turner-Bowker, Diane M.
    Yaworsky, Andrew
    Palladino, Andrew
    Lamoureux, Roger E.
    Kelly, Masami
    Love, Emily
    Pleil, Andreas M.
    Shields, Alan
    Loftus, Jane
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2020, 13 (03): : 289 - 306
  • [46] Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency
    Herschbach, P
    Henrich, G
    Strasburger, CJ
    Feldmeier, H
    Marín, F
    Attanasio, AM
    Blum, WF
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 145 (03) : 255 - 265
  • [47] One-year follow-up of quality of life in adults with untreated growth hormone deficiency
    Badia, X
    Lucas, A
    Sanmartí, A
    Roset, M
    Ulied, A
    CLINICAL ENDOCRINOLOGY, 1998, 49 (06) : 765 - 771
  • [48] Growth hormone deficiency and replacement in adults - Useful in those with reduced quality of life or bone mineral density
    Shalet, SM
    BRITISH MEDICAL JOURNAL, 1996, 313 (7053): : 314 - 314
  • [49] Ten-Year Change in Quality of Life in Adults on Growth Hormone Replacement for Growth Hormone Deficiency: An Analysis of the Hypopituitary Control and Complications Study
    Mo, Daojun
    Blum, Werner F.
    Rosilio, Myriam
    Webb, Susan M.
    Qi, Rong
    Strasburger, Christian J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (12): : 4581 - 4588
  • [50] BONE Mineral Density and Quality of Life in Adults with Growth Hormone Deficiency Treated with Recombinant Human Growth Hormone Therapy during 7 YEARS
    Partida Munoz, Myriam Lorena
    Allo Miguel, Gonzalo
    Soledad Librizzi, Maria
    Guadalix Iglesias, Sonsoles
    Martinez Diaz-Guerra, Guillermo
    Serraclara Pla, Alicia
    Hawkins, Ederico G.
    ENDOCRINE REVIEWS, 2014, 35 (03)
12345